[ad_1]
Preston Klbaden, MD, Head of Research and Development at Arena Pharmaceuticals, discusses Arena's exploration of potential uses of EraSimod outside of inflammatory bowel disease and the disease. The importance of designing treatments that facilitate treatment adherence for patients.
Source link